ARC Future Fellowships - Grant ID: FT130100654

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/FT130100654

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Investigating the actions of anti-inflammatory pathways in chronic lung disease. There is an urgent need to develop better drugs for Chronic Obstructive Pulmonary Disease (COPD) as patients become resistant to currently used anti-inflammatory drugs with disease progression. This research will uncover fundamental biology into an important class of anti-inflammatory receptor termed ALX/FPR2. This receptor normally coordinates the clearance of infection and injured tissue and subsequently switches off inflammation. Essential knowledge into why this receptor pathway fails to switch off inflammation will be determined. Furthermore, the development of targeting strategies to this receptor represents an innovative approach to blocking damaging and chronic airway inflammation.

Funded Activity Details

Start Date: 01-01-2014

End Date: 31-12-2018

Funding Scheme: ARC Future Fellowships

Funding Amount: $850,740.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases | Cardiorespiratory Medicine and Haematology | Basic Pharmacology | Innate Immunity

ANZSRC Socio-Economic Objective (SEO)

Respiratory System and Diseases (incl. Asthma) | Immune System and Allergy |

Other Keywords

Basic Pharmacology | Cardiorespiratory Medicine and Haematology | Immune System and Allergy | Innate Immunity | Respiratory Diseases | Respiratory System and Diseases (incl. Asthma)

Related Links